We get 40 to 50 first-generic submissions a year, and we make quick decisions and approvals on them, often on the same day the patent or exclusivity expires.

152

The generic-drug program is very important to the F.D.A..

145

We are very aware that many, many people are waiting for more generics to be approved and that there is frustration about the backlog.

110